Part D helps generics eat into brand name heartburn drug market share

NEW YORK With Medicare Part D’s prescription drug plans seeing an increase in enrollment in 2006, sales of heartburn medications rose as well, according to the Associated Press. The plans, though, focus on generic medications like Prilosec’s omeprazole over such market giants as Protonix and Nexium.

Heartburn medications were the second largest class of drug by sales and grossed almost $14 billion last year. The IMS reports that Part D had such an effect on the amount of generic omeprazole sold in 2006, "that the plan’s use of the drug exceeded the proton pump inhibitor market by 11 percent.

The heartburn market will only get more cluttered with drugs in the future, as not only brand name drugs will compete with each other and generics, but generics will also be in competition with one another with the final approval granted to Teva Pharmaceuticals to release a generic version of Protonix.

Poll

Poll

SPECIAL REPORTS

Are we in the midst of a beauty revolution? Perhaps. It is no secret that the ever-changing beauty category is all about trends, but one could argue that we are embarking on an especially interesting time in beauty as technology is changing the way consumers shop and new innovations strive to break through the noise.

In this beauty report, Drug Store News takes a deeper dive into some of the leading trends that are reshaping beauty.more ...

IN THIS ISSUE

In this issue, DSN examines PricewaterhouseCoopers' "Top Health Industry Issues for 2015;" takes you on a tour of Murad, shares beauty trends and insights and delves into location-based technology and how it is revolutionizing health, retail.Click here to view the issue.